Breast Cancer WEight Loss Study (BWEL Study)

Running, not enrolling · Phase 3

Conditions studied: Breast Carcinoma

In brief

This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence). Previous studies have found that women who are overweight or obese when their breast cancer is found (diagnosed) have a greater risk of their breast cancer recurring, as compared to women who were thinner when their cancer was diagnosed. This study aims to test whether overweight or obese women who take part in a weight loss program after being diagnosed with breast cancer have a lower rate of cancer recurrence as compared to women who do not take part in the weight loss program. This study will help to show whether weight loss programs should be a part of breast cancer treatment.

Key facts

Study ID
NCT02750826
Run by
Alliance for Clinical Trials in Oncology
People needed
3177
Starts
2016-09-16
Expected to finish
2030-05-30
Last updated by the study team
2025-01-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.